Welcome to LookChem.com Sign In|Join Free
  • or
Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethyl-, also known as Methylene Blue, is a synthetic dye and medication with the molecular formula C17H18N2OS. It is a blue-green crystalline powder that exhibits a variety of industrial and research applications, including its use as a neuroprotective and antidepressant agent. However, it is also considered toxic and should be handled with caution.

10205-71-7

Post Buying Request

10205-71-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10205-71-7 Usage

Uses

Used in Medical Applications:
Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylis used as a medication for treating methemoglobinemia and cyanide poisoning. It functions by reducing methemoglobin to hemoglobin, thereby restoring the oxygen-carrying capacity of the blood.
Used in Staining Biological Tissues:
In research, Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylis used as a staining agent for biological tissues. Its blue-green color allows for the visualization and differentiation of various cellular structures.
Used in Neuroprotective Applications:
Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylhas been studied for its potential neuroprotective effects. It may help protect neurons from damage and degeneration, making it a promising candidate for the treatment of neurodegenerative diseases.
Used in Antidepressant Applications:
Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylhas also been investigated for its potential antidepressant effects. It may help alleviate symptoms of depression by modulating neurotransmitter levels and promoting neuronal function.
Used in Industrial Applications:
In addition to its medical and research uses, Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylis utilized in various industrial applications, such as in the production of dyes, pigments, and other chemical products. Its blue-green color and chemical properties make it a valuable component in these industries.
However, it is important to note that due to its toxic nature, Benzenamine, 4-(6-methoxy-2-benzothiazolyl)-N,N-dimethylshould be handled with caution and used in accordance with safety guidelines to minimize potential health risks.

Check Digit Verification of cas no

The CAS Registry Mumber 10205-71-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,0 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10205-71:
(7*1)+(6*0)+(5*2)+(4*0)+(3*5)+(2*7)+(1*1)=47
47 % 10 = 7
So 10205-71-7 is a valid CAS Registry Number.

10205-71-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(6-Methoxy-1,3-benzothiazol-2-yl)-N,N-dimethylaniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10205-71-7 SDS

10205-71-7Downstream Products

10205-71-7Relevant academic research and scientific papers

Metal-chelating benzothiazole multifunctional compounds for the modulation and 64Cu PET imaging of Aβ aggregation

Bandara, Nilantha,Cho, Hong-Jun,Huang, Yiran,Mirica, Liviu M.,Rogers, Buck E.,Sun, Liang,Tran, Diana

, p. 7789 - 7799 (2020)

While Alzheimer's Disease (AD) is the most common neurodegenerative disease, there is still a dearth of efficient therapeutic and diagnostic agents for this disorder. Reported herein are a series of new multifunctional compounds (MFCs) with appreciable affinity for amyloid aggregates that can be potentially used for both the modulation of Aβ aggregation and its toxicity, as well as positron emission tomography (PET) imaging of Aβ aggregates. Firstly, among the six compounds tested HYR-16 is shown to be capable to reroute the toxic Cu-mediated Aβ oligomerization into the formation of less toxic amyloid fibrils. In addition, HYR-16 can also alleviate the formation of reactive oxygen species (ROS) caused by Cu2+ ions through Fenton-like reactions. Secondly, these MFCs can be easily converted to PET imaging agents by pre-chelation with the 64Cu radioisotope, and the Cu complexes of HYR-4 and HYR-17 exhibit good fluorescent staining and radiolabeling of amyloid plaques both in vitro and ex vivo. Importantly, the 64Cu-labeled HYR-17 is shown to have a significant brain uptake of up to 0.99 ± 0.04 percentID per g. Overall, by evaluating the various properties of these MFCs valuable structure-activity relationships were obtained that should aid the design of improved therapeutic and diagnostic agents for AD. This journal is

Intramolecular cascade C-S bond formation: Regioselective synthesis of substituted benzothiazoles

Bose, D. Subhas,Idrees, Mohd.

experimental part, p. 1983 - 1988 (2010/08/13)

Carbon-fluorine bond fission has been coupled with C-S bond formation under metal-free conditions, which is seldom reported in the literature. The intramolecular C-S bond formation reaction takes place by fission of the carbon-fluorine bond in situ, and is believed to proceed through an S NAr mechanism. The approach represents a practical and atom-economical approach for regioselective and metal-free cascade synthesis of substituted benzothiazoles. This one-pot, environmentally benign protocol involves 2-fluoroanilines, benzoyl chlorides and Lawessons reagent under microwave irradiation (5 min) or conventional thermal conditions (3h). Georg Thieme Verlag Stuttgart.

Dess-martin periodinane mediated intramolecular cyclization of phenolic azomethines: A solution-phase strategy toward benzoxazoles and benzothiazoles

Bose, D. Subhas,Idrees, Mohd.

experimental part, p. 398 - 402 (2010/04/03)

Dess-Martin periodinane (DMP), a highly versatile hypervalent iodine(V) reagent, was found to efficiently mediate the intramolecular cyclization of phenolic azomethines/Schiff bases at ambient temperature leading to the rapid and expeditious synthesis of substituted benzoxazoles and benzothiazoles. Furthermore, a solution-phase strategy has been developed by treating the reaction mixtures sequentially with Amberlyst A-26 thiosulfate resin and diisopropylaminomethyl resin (PS-DIEA), which remove excess reagent and byproducts, to give pure products. Georg Thieme Verlag Stuttgart - New York.

A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution

Auld, Douglas S.,Zhang, Ya-Qin,Southall, Noel T.,Rai, Ganesha,Landsman, Marc,MacLure, Jennifer,Langevin, Daniel,Thomas, Craig J.,Austin, Christopher P.,Inglese, James

supporting information; experimental part, p. 1450 - 1458 (2009/12/26)

We measured the "draggability" of the ATP-dependent luciferase derived from the firefly Photuris pennsylvanica that was optimized using directed evolution (Ultra-Glo, Promega). Quantitative high-throughput screening (qHTS) was used to determine IC50

Synthesis of 2-arylbenzothiazoles by DDQ-promoted cyclization of thioformanilides; a solution-phase strategy for library synthesis

Bose, D. Subhas,Idrees,Srikanth, Bingi

, p. 819 - 823 (2007/12/29)

Several substituted benzothiazoles were synthesized by the intramolecular cyclization of thioformanilides using 2,6-dichloro-3,5-dicyano-1,4-benzoquinone (DDQ) in dichloromethane at ambient temperature in high yields. The resulting 2-arylbenzothiazoles we

One-step synthesis of 2-arylbenzothiazole ('BTA') and -benzoxazole precursors for in vivo imaging of β-amyloid plaques

Alagille, David,Baldwin, Ronald M.,Tamagnan, Gilles D.

, p. 1349 - 1351 (2007/10/03)

We report the simple and efficient synthesis of 2-arylbenzothiazoles ('BTA') and 2-arylbenzoxazoles by direct coupling of benzothiazoles or benzoxazoles with aryl bromides. This method permits direct one-step access to precursors of radiolabeled BTA-1 and

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

-

Page 15 - 16, (2008/06/13)

This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising the thioflavin derivatives and method of synthesizing the

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Mathis, Chester A,Wang, Yanming,Holt, Daniel P,Huang, Guo-Feng,Debnath, Manik L,Klunk, William E

, p. 2740 - 2754 (2007/10/03)

The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [(11)C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (or [(11)C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [(11)C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-(3)H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Abeta(1-40) fibrils were similar (K(d) = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Abeta peptide binding stoichiometry was approximately 400-fold higher for AD brain than Abeta(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [(11)C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Abeta deposition.

Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition

-

, (2008/06/13)

This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising the thioflavin derivatives and method of synthesizing the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 10205-71-7